The European Union is taking a further step in its preparations for crises that may include nuclear, radiological, biological or chemical (NRBQ) attacks. Brussels has begun to mobilise the pharmaceutical industry to ensure that it can rapidly increase drug production and other countermeasures in an emergency, a strategy that coincides with the growth of Spanish companies in this sector that already moves 298 million, 33% since the start of the w…
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.
The European Union is taking a further step in its preparations for crises that may include nuclear, radiological, biological or chemical (NRBQ) attacks. Brussels has begun to mobilise the pharmaceutical industry to ensure that it can rapidly increase drug production and other countermeasures in an emergency, a strategy that coincides with the growth of Spanish companies in this sector that already moves 298 million, 33% since the start of the w…